PRISM Early-Stage Parkinson’s Disease Study


AGE: 30 - 80 years old
TYPE: Investigational Drug Study
CONDITION: Early-stage Parkinson’s Disease
COMPENSATION: May be available

Learn More About This Research Study

For more information, please contact Libby Schubert, the study coordinator at 216-844-2381 or complete the online form below.

Study Purpose

The PRISM Parkinson’s Research Study is evaluating an investigational drug to determine if it might slow down the progression of Parkinson’s disease (PD). Patients who enroll in this study will receive the study drug weekly over a period of 36 weeks. Participants will have about 10 scheduled in-person visits at the study center and 5 scheduled telephone visits. Those who enroll can expect to be in the study for a total of 44 weeks.

Who Can Participate

Participants between 30 and 80 years of age who are diagnosed with early-stage Parkinson’s Disease and are not on any current treatments for the disease.

Request More Information

To learn more about this study, please fill out the form below to request more information.


Study ID

  • 20192851